HiTech Health

HiTech Health is a specialized CDMO focused on the high-growth cell and gene therapy sector, offering critical manufacturing and regulatory support services from its GMP facility in Dublin. Founded in 2015, it positions itself as an enabler for biotech and pharmaceutical companies looking to commercialize advanced therapies in Europe. Its core value proposition lies in providing aseptic fill-finish capabilities and QP services, addressing key bottlenecks in the supply chain for complex therapies. The company serves a diverse client base across cell & gene therapy, pharmaceuticals, biotechnology, and medical devices.

EU/EMA-certified GMP facility specializing in sterile/aseptic manufacturing and fill-finish for cell and gene therapies, with integrated Qualified Person (QP) release services.

HiTech Health competes in the fragmented but consolidating advanced therapy CDMO market. It faces competition from global giants (Lonza, Catalent, Thermo Fisher), large biopharma CDMOs (Samsung Biologics, Fujifilm Diosynth), and other niche CGT-focused players (Oxford Biomedica, Genezen). Its differentiation lies in its specialized aseptic fill-finish and integrated EU/UK regulatory services.